MIT Open Access Articles
The MIT Open Access Articles collection consists of scholarly articles written by MIT-affiliated authors that are made available through DSpace@MIT under the MIT Faculty Open Access Policy, or under related publisher agreements. Articles in this collection generally reflect changes made during peer-review.
Version details are supplied for each paper in the collection:
- Original manuscript: author's manuscript prior to formal peer review
- Author's final manuscript: final author's manuscript post peer review, without publisher's formatting or copy editing
- Final published version: final published article, as it appeared in a journal, conference proceedings, or other formally published context (this version appears here only if allowable under publisher's policy)
Some peer-reviewed scholarly articles are available through other DSpace@MIT collections, such as those for departments, labs, and centers.
If you are an MIT community member who wants to deposit an article into the this collection, you will need to log in to do so. If you don't have an account, please contact us.
More information:
Recent Submissions
-
Targeting and monitoring ovarian cancer invasion with an RNAi and peptide delivery system
(Proceedings of the National Academy of Sciences, 2024-03-04)RNA interference (RNAi) therapeutics are an emerging class of medicines that selectively target mRNA transcripts to silence protein production and combat disease. Despite the recent progress, a generalizable approach for ... -
Carboxylated Nanoparticle Surfaces Enhance Association with Mucoid Pseudomonas aeruginosa Biofilms
(American Chemical Society, 2024-03-14)Pseudomonas aeruginosa biofilms comprise three main polysaccharides: alginate, psl, and pel, which all imbue tolerance against exogenous antimicrobials. Nanoparticles (NPs) are an exciting new strategy to overcome the ... -
Poly(β-aminoester) Physicochemical Properties Govern the Delivery of siRNA from Electrostatically Assembled Coatings
(American Chemical Society, 2024-04-30)Localized short interfering RNA (siRNA) therapy has the potential to drive high-specificity molecular-level treatment of a variety of disease states. Unfortunately, effective siRNA therapy suffers from several barriers to ...